期刊文献+

隐球菌抗原MP98的HLA-A*0201限制性CD8+CTL表位的预测及鉴定 被引量:2

Prediction and Identification of HLA-A*0201 Restricted CD8+CTL Epitopes in Cryptococcus Neoformans MP98
下载PDF
导出
摘要 目的鉴定隐球菌抗原MP98中的HLA-A*0201限制性CD8+CTL表位。方法应用数据库SYFPEITHI预测隐球菌MP98中可能存在的HLA-A*0201限制性CD8+CTL表位,经流式细胞术分析各抗原肽与HLA-A*0201的亲合力,经时间分辨荧光法检测外周血单个核细胞(PBMCs)对各抗原肽产生的增殖反应,经细胞毒性实验研究各抗原肽诱导的特异性T细胞的细胞毒杀伤活性,逐步鉴定MP98的HLA-A*0201限制性CD8+CTL表位。结果位于MP98氨基酸序列肽5(436-444aa)与HLA-A*0201分子具有较高的亲合力,并都能刺激HLA-A*0201阳性个体者PBMC增殖,并诱导产生具有特异性杀伤活性的CTL。结论肽5GMFDGLSGV(436-444aa)是MP98上HLA-A*0201限制性CD8+CTL的优势表位,可作为隐球菌疫苗设计的候选表位。 Objective To identify HLA-A * 0201 restricted CD8+CTL epitopes in Cryptococcus neoformans MP98. Methods Firstly,database SYFPEITHI was applied to predict HLA-A * 0201 restricted CD8+CTL epitopes in Cryptococcus neoformans MP98. Secondly,affinity and stability of the predicted peptides with T2 cell were assayed by flow cytometry. Thirdly,cells proliferation and cytotoxicity induced by peptides were investigated by DELFIA cell proliferation assay and DELFIA EUTDA cytotoxicity test respectively. Results Peptide 5 (GMFDGLSGV,436-444aa)had high affinity with HLA-A * 0201 molecules,stimulated PBMCs from healthy donors to proliferate and induce antigen specific CTLs. Only pep6 could give a positive proliferation response and specific cytotoxicity. Conclusion Pep 5 GMFDGLSGV(436-444aa)is HLA-A * 0201 restricted CDS+CTL epitope of Cryptococcus neoformans MP98,which could be the candidate for peptide- based vaccine.
出处 《现代检验医学杂志》 CAS 2008年第2期1-4,共4页 Journal of Modern Laboratory Medicine
基金 国家自然科学基金(30671840) 上海市卫生局科研计划项目(044092)资助
关键词 隐球菌 细胞毒性T细胞 抗原表位 疫苗 Cryptococcus neoformans cytotoxic T lymphocyte epitope vaccine
  • 相关文献

参考文献8

  • 1Horcaiada JP,Pena JL,Martinez-Taboada VM,et al. Invasive Cryptococcosis and adalimumab treatment[J]. Emerg Infect Dis, 2007,13 (6):953-955.
  • 2Lakshmi V, Sudha T, Teja VD, et al. Prevalence of central nervous system Cryptococcosis in human immunodeficiency virus reactive hospitalized patients [J]. Indian J Med Microbiol , 2007,25 (2) : 146-149.
  • 3Datta K,Pirofski LA. Towards a vaccine for Cryptococcus neoformans., principles and caveats [J]. FEMS Yeast Res, 2006,6 (4) : 525-536.
  • 4Levitz SM, Nong S, Mansour MK, et al. Molecular characterization of a mannoprotein with homology to chitin deaeetylases that stimulates T cell responses to Cryptococcus neoformans [J ]. Proc Natl Acad Sci USA,2001,98(18) :10422-10427.
  • 5吴传勇,娄加陶,蒋廷旺,钱,周晔,陈燕,陈波,谷明莉,邓安梅,仲人前.结核杆菌抗原Ag85C的HLA-A*0201限制性CD8^+CTL表位的预测及鉴定[J].第二军医大学学报,2007,28(4):349-354. 被引量:7
  • 6陈孙孝,温海,陈江汉,顾菊林,邓安梅.隐球菌病患者中NK细胞活性降低及其意义[J].第二军医大学学报,2006,27(2):120-124. 被引量:6
  • 7Zhou Q,Gault RA,Kozel TR,et al. Protection from direct cerebral Cryptococcus infection by interferon-gamma-dependent activation of microglial cells[J]. J Immunol,2007,178(9):5753-5761.
  • 8Huang C,Nong SH,Mansour MK,et al. Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses[J]. Infect Immun, 2002, 70(10) z 5485-5493.

二级参考文献27

  • 1Fournier Y,Bellini C,Baur AS,et al.Disseminated cryptococcosis as inaugural manifestation of AIDS[J].Schweiz Rundsch Med Prax,2005,94:17-23.
  • 2Jacobs R,Heiken H,Schmidt RE.Mutual interference of HIV and natural killer cell-mediated immune response[J].Mol Immunol,2005,42:239-249.
  • 3Korbel DS,Finney OC,Riley EM.Natural killer cells and innate immunity to protozoan pathogens[J].Int J Parasitol,2004,34:1517-1528.
  • 4Murphy JW,Zhou A,Wong SC.Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production[J].Infect Immun,1997,65:4564-4571.
  • 5Alter G,Malenfant JM,Delabre RM,et al.Increased natural killer cell activity in viremic HIV-1 infection[J].J Immunol,2004,173:5305-5311.
  • 6Siddiqui AA,Brouwer AE,Wuthiekanun V,et al.IFN-γ at the site of infection determines rate of clearance of infection in Cryptococcal meningitis[J].J Immunol,2005,174:1746-1750.
  • 7Bottino C,Moretta L,Pende D,et al.Learning how to discriminate between friends and enemies,a lesson from natural killer cells[J].Mol Immunol,2004,41:569-575.
  • 8Global Tuberculosis Control:Surveillance,Planning,Finacing.WHO report 2004,Geneva,Switzerland,2004.
  • 9Tuberculosis.WHO Fact Sheet No 104 Revised August 2002.http://www.who.int/mediacentre/factsheets/fs104/en.
  • 10Tracevska T,Jansone I,Baumanis V,et al.Prevalence of Beijing genotype in Latvian multidrug-resistant Mycobacterium tuberculosis isolates[J].Int J Tuberc Lung Dis,2003,7:1097-1103.

共引文献11

同被引文献11

  • 1陈孙孝,温海,陈江汉,顾菊林,邓安梅.隐球菌病患者中NK细胞活性降低及其意义[J].第二军医大学学报,2006,27(2):120-124. 被引量:6
  • 2钱,陈孙孝,吴传勇,蒋廷旺,王燕,周晔,陈燕,陈波,邓安梅,仲人前.颗粒溶素酶联免疫吸附测定法的建立及临床初步应用[J].中华检验医学杂志,2006,29(11):1018-1020. 被引量:5
  • 3吴传勇,娄加陶,蒋廷旺,钱,周晔,陈燕,谷明莉,邓安梅,仲人前.结核杆菌抗原多表位融合蛋白的重组表达与鉴定[J].第二军医大学学报,2006,27(12):1281-1285. 被引量:10
  • 4Segal BH,Steinbach WJ. Combination antifungals :an update [J]. Expert Rev Anti Infect Ther , 2007,5 (5) : 883-889.
  • 5Sobhani R, Basavarai A, Gupta A,et al. Mortality & clinical characteristics of hospitalized adult patients with HIV in Pune ,India[J]. Indian J Med Res, 2007, 126(2) :116-121.
  • 6Saha DC,Goldman DL,Shao X,et al. Serologic evidence for reactivation of Cryptococcosis in solid-organ transplant recipients [J]. Clin Vaccine Immunol, 2007,14(12): 1550-1554.
  • 7Chen HS,Tsai WP,Leu HS,et al. Invaslve fungal infection in systemic lupus erythematosus:an analysis of 15 cases and a literature review[J]. Rheumatology (Oxford), 2007,46(3) :539-544.
  • 8谷明莉 钱琤 邓安梅 等.QLFATINSTL(93-102aa)是隐球菌抗原MP98 C Granulysin,acytolytic molecle,TL优势表位.临床军医杂志,.
  • 9Anmei Deng, Sunxiao Chen, Qing Li, et al. Granulysin,a cytolytic molecle ,is also a chemoattractant and Proinflammatory Activator[J]. Journal of Imunology, 2005,174 (9) : 5243-5248.
  • 10周晔,吴传勇,娄加陶,蒋天舒,陈燕,陈波,谷明莉,仲人前,邓安梅.结核分枝杆菌保护性肽表位KLIANNTRV多聚体的免疫原性研究[J].中华结核和呼吸杂志,2007,30(11):868-869. 被引量:3

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部